Marker Therapeutics, Inc. (MRKR)

NASDAQ: MRKR · IEX Real-Time Price · USD

5.24

-0.10 (-1.87%)

At close: Jul 2, 2024, 4:00 PM

4.990

-0.250 (-4.77%)

After-hours: Jul 2, 2024, 4:44 PM EDT

Marker Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-8.24	-29.93	-41.88	-28.71	-21.43	Upgrade
Depreciation & Amortization	0	0	3.16	1.08	0.29	Upgrade
Share-Based Compensation	0.86	3.3	5.96	5.23	5.36	Upgrade
Other Operating Activities	-9.06	-0.35	5.47	2.37	-2.5	Upgrade
Operating Cash Flow	-16.44	-26.97	-27.28	-20.03	-18.28	Upgrade
Capital Expenditures	0	0	-3.13	-9.25	-0.37	Upgrade
Other Investing Activities	18.66	-4.95	-	-	-	Upgrade
Investing Cash Flow	18.66	-4.95	-3.13	-9.25	-0.37	Upgrade
Share Issuance / Repurchase	1.11	0.2	52.56	6.74	0.82	Upgrade
Financing Cash Flow	1.11	0.2	52.56	6.74	0.82	Upgrade
Net Cash Flow	3.33	-31.72	22.14	-22.55	-17.84	Upgrade
Free Cash Flow	-16.44	-26.97	-30.41	-29.29	-18.66	Upgrade
Free Cash Flow Margin	-496.51%	-767.66%	-2449.11%	-6274.32%	-8752.25%	Upgrade
Free Cash Flow Per Share	-1.87	-3.23	-3.98	-6.23	-4.09	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).